Cullinan Management Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

    NEXT STORY
    Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer
    PREV STORY
    Roche confirms US government agreement to purchase additional doses of Regeneron’s casirivimab and imdevimab
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Invuity Reports 2016 First Quarter Results

    SAN FRANCISCO, May 05, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical ...

    author_avatar
    NASDAQ Market News

    ContraVir Pharmaceuticals Announces Issuance of New US Patent for Expansion of Cyclophilin Inhibitor Program

    EDISON, N.J., Aug. 21, 2017 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Generex Biotechnology Announces New Updated Agenda for Shareholder Conference Call on Wednesday August 26th, 2020 at 9:30 AM

    author_avatar
    NASDAQ Market News